Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

4 forces favoring, 5 working against Biden’s wish to lower Medicare eligibility age

President-elect Joe Biden wants to drop Medicare’s eligibility age to 60. If he succeeds, the move might bring in well more than 20 million new enrollees. What are the odds he’ll plant that piece of a potentially sweeping healthcare agenda?  

Thumbnail

3 areas newly ripe for employer-driven change in healthcare policy

A healthcare research firm specializing in purchasing has considered the post-election landscape from the vantage point of large employers offering health benefits to their workers.

Health execs best consider now what a ‘Bidencare’ might look like later

As Joe Biden makes plans to intensify the federal response to the COVID crisis, he can expect support on that agenda item from 77% of Democrats, 62% of independents, 55% of Republicans and 50% of others.

Thumbnail

AI with location data may fine-tune flu forecasting

The researchers say their AI technique produces an 11% boost in accuracy over that supplied by other contemporary flu forecasting systems.

Physicians historically turn out to vote—or sit it out—in curious patterns

Physicians who lived in three of the most populous states and were eligible to vote from 2006 to 2018 did so at a rate 14 percentage points lower than the population as a whole.

Thumbnail

Surveyed physicians up for hybrid healthcare, down on Medicare for All

U.S. physicians favor the idea of a two-tiered healthcare system, one in which a single-payer option peacefully coexists with private coverage. Their least favorite model? Single-payer Medicare for All.

Nearly all nursing homes are hurting, but should the for-profits get more free money?

Even after receiving $7.5 billion in federal COVID relief and billions more from the Paycheck Protection Program, nursing homes are still hurting financially. Should the field’s for-profit players have their hands out with the rest?

Brit study: Money-motivated parties weighed in heavily on FDA’s medical AI regulation

Of 125 public comments submitted to the FDA on how best to regulate AI software as a medical device, nearly two-thirds came from parties with financial ties to industry, according to a study running in BMJ Open.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.